You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 2, 2025

Drug Price Trends for NDC 63304-0904


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 63304-0904

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
VALACYCLOVIR HCL 500MG TAB Golden State Medical Supply, Inc. 63304-0904-30 30 24.00 0.80000 2023-06-15 - 2028-06-14 FSS
VALACYCLOVIR HCL 500MG TAB Golden State Medical Supply, Inc. 63304-0904-90 90 73.01 0.81122 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

63304-0904 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 63304-0904

Introduction

The National Drug Code (NDC) 63304-0904 identifies a specific pharmaceutical product, and understanding its market dynamics and price projections is crucial for stakeholders, including manufacturers, distributors, and healthcare providers. Here, we will delve into the key aspects of this drug, including its identification, market trends, and price projections.

Drug Identification

The NDC 63304-0904 is a unique identifier assigned by the FDA, consisting of three segments: the labeler code, product code, and package code. In this case:

  • Labeler Code: 63304, which identifies the manufacturer or distributor, such as Ranbaxy Pharmaceuticals Inc.[1][4].
  • Product Code: Specific to the drug formulation, strength, and dosage form.
  • Package Code: Indicates the package size and type.

Market Trends

The pharmaceutical market is subject to various factors that influence pricing and demand.

General Market Growth

The overall prescription drug market is expected to grow at a Compound Annual Growth Rate (CAGR) of 9% through 2030. This growth is driven by increasing healthcare needs, advancements in medical technology, and an aging population[3].

Competitive Landscape

The competitive landscape for any drug involves other products with similar indications and formulations. For a drug like metoclopramide (if we assume this NDC corresponds to metoclopramide, given the context of the provided sources), competition comes from other antiemetic and prokinetic agents.

Price Projections

Price projections for pharmaceuticals are influenced by several factors, including production costs, regulatory changes, market demand, and competition.

Current Pricing

To project future prices, it is essential to understand current pricing. However, specific pricing data for NDC 63304-0904 is not provided in the sources. Generally, prices for prescription drugs can be found in databases such as the Missouri Specialty MAC list or through drug price tracking services[2][3].

Factors Influencing Price

  • Regulatory Changes: Changes in FDA regulations or listing obligations can affect pricing. For instance, updates to the Drug Listing Act or changes in the NDC Directory can impact how drugs are marketed and priced[4].
  • Market Demand: Increased demand due to growing patient populations or new indications can drive prices up.
  • Production Costs: Changes in raw material costs, manufacturing processes, or supply chain disruptions can influence the final product price.
  • Competition: The presence of generic or branded competitors can lead to price adjustments to remain competitive.

Renal Impairment and Dosage Adjustments

For drugs like metoclopramide, which are affected by renal impairment, dosage adjustments can impact pricing. Patients with renal impairment may require lower doses, which could affect the overall cost of treatment. This is particularly relevant as the pharmacokinetics of metoclopramide are significantly affected by renal function[1].

Pharmacokinetics and Pharmacodynamics

Understanding the pharmacokinetics and pharmacodynamics of a drug is crucial for pricing projections, as it affects dosing regimens and treatment durations. For metoclopramide:

  • Volume of Distribution: High volume of distribution (about 3.5 L/kg) indicates extensive tissue distribution.
  • Plasma Protein Binding: Low plasma protein binding (about 30%) suggests a higher free fraction of the drug available for action.
  • Elimination Half-Life: The half-life of 5 to 6 hours influences dosing frequency and overall treatment cost[1].

Key Takeaways

  • Market Growth: The pharmaceutical market is expected to grow significantly, influencing demand and pricing.
  • Regulatory Compliance: Adherence to FDA regulations and updates to the NDC Directory are crucial for maintaining market presence.
  • Competitive Landscape: The presence of competitors and generic alternatives can impact pricing strategies.
  • Pharmacokinetics: Understanding the drug's pharmacokinetic profile is essential for dosing and cost considerations.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique, three-segment number that identifies a drug product, including the labeler, product, and package size[4].
  2. How does renal impairment affect the pricing of metoclopramide?

    • Renal impairment requires dosage adjustments, which can affect the overall cost of treatment due to the need for lower doses and potentially longer treatment durations[1].
  3. What factors influence the price projections of pharmaceuticals?

    • Factors include production costs, regulatory changes, market demand, and competition from other drugs[3].
  4. Why is it important to update drug listing data?

    • Updating drug listing data ensures compliance with FDA regulations and reflects any changes in the drug's marketing status or formulation[4].
  5. How does the pharmacokinetic profile of a drug impact its pricing?

    • The pharmacokinetic profile affects dosing regimens, treatment durations, and the overall cost of treatment, as it influences how the drug is metabolized and eliminated from the body[1].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.